New Data Presented At American Burn Association’s Annual Meeting Support Safety Profile Of RECOTHROM® Thrombin, Topical In Pediatric Patients
ZymoGenetics, Inc. (NASDAQ:ZGEN), today announced the presentation of safety and immunogenicity data among pediatric burn patients at the 42nd Annual Meeting of the American Burn Association in Boston, MA. The study marks the first dedicated look at the safety and immunogenicity of any stand-alone thrombin in pediatric surgical patients…
Also tagged American Burn Association, Annual Meeting, Boston Ma, Immunogenicity, Nasdaq, Pediatric Patients, Presentation, Safety Profile, Support Safety, Thrombin, Zgen, Zymogenetics Inc
